| scholarly article | Q13442814 |
| P2093 | author name string | J J Kim | |
| D B Weiner | |||
| D J Lee | |||
| M S Wyand | |||
| J S Yang | |||
| J D Boyer | |||
| K E Ugen | |||
| K H Manson | |||
| T C VanCott | |||
| P2860 | cites work | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1 | Q24643931 |
| Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination | Q24646818 | ||
| In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. | Q33639596 | ||
| Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. | Q34425543 | ||
| Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. | Q35874803 | ||
| Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. | Q35886254 | ||
| Gene inoculation generates immune responses against human immunodeficiency virus type 1 | Q36284135 | ||
| Protection against vaginal SIV transmission with microencapsulated vaccine | Q38565318 | ||
| Vaccination against tuberculosis by DNA injection | Q41182163 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Direct gene transfer into nonhuman primate myofibers in vivo | Q43851694 | ||
| Genetic immunization is a simple method for eliciting an immune response | Q43857336 | ||
| Direct gene transfer into mouse muscle in vivo | Q44656494 | ||
| Towards an HIV-1 vaccine: lessons from studies in macaque models | Q47773787 | ||
| Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. | Q52845358 | ||
| Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines | Q72641753 | ||
| Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens | Q74442122 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 3427-3429 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants | |
| P478 | volume | 74 |
| Q44222584 | A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. |
| Q40545484 | A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection |
| Q33883854 | A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates |
| Q37373730 | Adjuvants for porcine reproductive and respiratory syndrome virus vaccines |
| Q53674181 | An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming. |
| Q38019442 | An overview of infectious bursal disease |
| Q35851809 | Approaches for the design and evaluation of HIV-1 DNA vaccines |
| Q89712283 | CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine |
| Q43855252 | Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection |
| Q73816627 | Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65 |
| Q51346706 | Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model. |
| Q81396898 | DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication |
| Q35745831 | DNA vaccines against human immunodeficiency virus type 1 in the past decade |
| Q33208276 | DNA vaccines and their application against parasites--promise, limitations and potential solutions. |
| Q39976443 | Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs |
| Q37384713 | Enhanced potency of replicon vaccine using one vector to simultaneously co-express antigen and interleukin-4 molecular adjuvant |
| Q34342982 | Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G |
| Q35826378 | Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants |
| Q45415883 | Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1. |
| Q28250092 | From plasmids to protection: a review of DNA vaccines against infectious diseases |
| Q34189226 | Genetic adjuvants for DNA vaccines |
| Q43953909 | IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques |
| Q45304475 | Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice |
| Q54355479 | Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes. |
| Q73636717 | Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants |
| Q46498023 | Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes |
| Q51890555 | Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. |
| Q43581520 | Plasmid DNA encoding caprine interferon gamma inhibits antibody response to caprine arthritis-encephalitis virus (CAEV) surface protein encoded by a co-administered plasmid expressing CAEV env and tat genes |
| Q38876358 | Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa |
| Q37996192 | Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo |
| Q49377121 | Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation |
| Q27016078 | Synthetic DNA vaccine strategies against persistent viral infections |
| Q35802958 | Technologies for enhanced efficacy of DNA vaccines |
| Q36960508 | The potential of topical DNA vaccines adjuvanted by cytokines |
| Q35951849 | The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses |
| Q30329791 | Vaccine development against HIV-1: current perspectives and future directions. |
| Q35531553 | Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus |
| Q34332708 | Vaccines for the prevention of HIV-1 disease |
Search more.